Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M37.5Revenue $M0.1Net Margin (%)-11,930.1Z-Score-33.1
Enterprise Value $M38.7EPS $-4.0Operating Margin %-10,431.6F-Score0
P/E(ttm))0Cash Flow Per Share $0Pre-tax Margin (%)-11,928.6Higher ROA y-yN
Price/Book010-y EBITDA Growth Rate %0Quick Ratio4.0Cash flow > EarningsN
Price/Sales70.45-y EBITDA Growth Rate %0Current Ratio4.1Lower Leverage y-yN
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-186.9Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)8ROE % (ttm)-1,148.5Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M16.0ROI % (ttm)0Gross Margin Increase y-yN

Gurus Latest Trades with BIOC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

BIOC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


BIOC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROYSTON IVORDirector 2015-02-13Buy12,000$1.2587.2 view
Chandler Marsha AlpertDirector 2015-02-13Buy2,000$1.2587.2 view
Wilson Margaret FayeDirector 2015-02-13Buy4,000$1.2587.2 view
Neff Edward A.Director 2015-02-13Buy40,000$1.2587.2 view
Nall Michael W.CEO & President 2015-02-13Buy12,000$1.2587.2 view
HUEBNER BRUCE ADirector 2015-02-13Buy12,000$1.2587.2 view
HALE DAVID FChairman 2015-02-13Buy40,000$1.2587.2 view
Gerhardt BruceDirector 2015-02-13Buy20,000$1.2587.2 view
BERG JEFFREY HDirector 2012-03-07Sell5,000$5.55-57.84 view
LoCastro MarcellaDirector 2011-12-16Buy1,500$4.49-47.88 view

Press Releases about BIOC :

    Quarterly/Annual Reports about BIOC:

    News about BIOC:

    Articles On GuruFocus.com
    mbs Feb 25 2015 
    Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with Bris Feb 23 2015 

    More From Other Websites
    Most active Nasdaq-traded stocks Apr 13 2015
    Biocept Enters Clinical Collaboration With University of California, San Diego Moores Cancer Center Mar 24 2015
    Biocept Enters Clinical Collaboration With University of California, San Diego Moores Cancer Center Mar 24 2015
    BIOCEPT INC Financials Mar 18 2015
    BIOCEPT INC Files SEC form 10-K, Annual Report Mar 11 2015
    Biocept Expands Non-Small Cell Lung Cancer Diagnostic Capabilities for EGFR Mutations Mar 10 2015
    Biocept Expands Non-Small Cell Lung Cancer Diagnostic Capabilities for EGFR Mutations Mar 10 2015
    Biocept Reports Fourth Quarter 2014 Financial Results Mar 09 2015
    BIOCEPT INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Mar 09 2015
    Biocept Reports Fourth Quarter 2014 Financial Results Mar 09 2015
    Next Generation Sequencing Veteran Joins Biocept Mar 05 2015
    Next Generation Sequencing Veteran Joins Biocept Mar 05 2015
    Biocept to Present at the 27th Annual ROTH Conference Mar 03 2015
    Biocept to Present at the 27th Annual ROTH Conference Mar 03 2015
    Dr. David Rimm Joins Biocept, Inc. as a Scientific Advisor Mar 02 2015
    Dr. David Rimm Joins Biocept, Inc. as a Scientific Advisor Mar 02 2015
    Has Biocept Reached an Inflection Point? Feb 26 2015
    Biocept, Inc. Schedules Webcast and Conference Call for Fourth Quarter 2014 Financial Results Feb 25 2015
    Biocept Breaks Through With Columbia Study Feb 23 2015
    BUZZ-U.S. STOCKS ON THE MOVE-Biocept, Rigel, Spectrum Feb 23 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK